Evidence map›Paper›PMID 34537017›Full record

ArticleBMC neurology2021

The role of hybrid FDG-PET/MRI on decision-making in presurgical evaluation of drug-resistant epilepsy.

Márton Tóth, Péter Barsi, Zoltán Tóth, Katalin Borbély, János Lückl, Miklós Emri, Imre Repa, József Janszky, Tamás Dóczi, Zsolt Horváth and 16 more

Abstract read
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.European journal of nuclear medicine and molecular imaging · 2024
    Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Quantitative Cortex-Based Mapping With HybridCNS neuroscience & therapeutics · 2025
    Article
  8. Long-term trends in total administered radiation dose from brain [European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Márton TóthDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary. toth.marton@pte.hu.ORCID https://orcid.org/0000-0003-1794-7260
Péter BarsiDepartment of Medical Imaging, Semmelweis University, Balassa út 6, Budapest, H-1083, Hungary.
Zoltán TóthDr. József Baka Diagnostic, Radiation oncology, Research and Teaching Center, Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.
Katalin BorbélyPET/CT Ambulance, National Institute of Oncology, Ráth György u.7-9, Budapest, H-1122, Hungary.
János LücklDr. József Baka Diagnostic, Radiation oncology, Research and Teaching Center, Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.
Miklós EmriMEDICOPUS Healthcare Provider and Public Nonprofit Ltd., Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.
Imre RepaDr. József Baka Diagnostic, Radiation oncology, Research and Teaching Center, Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.
József JanszkyDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Tamás DócziMTA-PTE Clinical Neuroscience MRI Research Group, Ifjúság u. 20, Pécs, H-7624, Hungary.
Zsolt HorváthDepartment of Neurosurgery, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Péter HalászNational Institute of Clinical Neurosciences, Amerikai út 57, Budapest, H-1145, Hungary.
Vera JuhosEpihope Non-Profit Kft, Szilágyi Erzsébet fasor 17-21, Budapest, 1026, Hungary.
Csilla GyimesiDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Beáta BónéDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Diána KuperczkóDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Réka HorváthDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Ferenc NagyDepartment of Neurology, Somogy County Moritz Kaposi Teaching Hospital, Sándor u. 40, Guba, H-7400, Hungary.
Anna KelemenNational Institute of Clinical Neurosciences, Amerikai út 57, Budapest, H-1145, Hungary.
Zsófia JordánNational Institute of Clinical Neurosciences, Amerikai út 57, Budapest, H-1145, Hungary.
Ákos ÚjváriNational Institute of Clinical Neurosciences, Amerikai út 57, Budapest, H-1145, Hungary.
Koichi HagiwaraEpilepsy and Sleep Center, Fukuoka Sanno Hospital, 3-6-45, Momochihama, Sawara-ku, Fukuoka, 814-0001, Japan.
Jean IsnardDepartment of Functional Neurology and Epileptology, Hospices Civils de Lyon, Hospital for Neurology and Neurosurgery Pierre Wertheimer, 59 Boulevard Pinel, 69500, Lyon, France.
Endre PálDepartment of Neurology, Medical School, University of Pécs, Rét u. 2, Pécs, H-7623, Hungary.
Attila FekésházyDr. József Baka Diagnostic, Radiation oncology, Research and Teaching Center, Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.
Dániel Fabó *National Institute of Clinical Neurosciences, Amerikai út 57, Budapest, H-1145, Hungary.ORCID https://orcid.org/0000-0001-5141-5351
Zsolt Vajda *Dr. József Baka Diagnostic, Radiation oncology, Research and Teaching Center, Somogy County Moritz Kaposi Teaching Hospital, Guba Sándor u. 40, Kaposvár, H-7400, Hungary.

Funding

Gazdaságfejlesztési és Innovációs Operatív Program GINOP-2.3.3-15-2016-00032Hungarian Brain Research Program 2017-1.2.1-NKP-2017-00002MEDICOPUS Healthcare Provider and Public Nonprofit Ltd 008899/2016/OTIGNemzeti Kutatási Fejlesztési és Innovációs Hivatal NKFIH EFOP-3.6.2-16-2017-00008
6 · The paper itself

Abstract

backgroundWhen MRI fails to detect a potentially epileptogenic lesion, the chance of a favorable outcome after epilepsy surgery becomes significantly lower (from 60 to 90% to 20-65%). Hybrid FDG-PET/MRI may provide additional information for identifying the epileptogenic zone. We aimed to investigate the possible effect of the introduction of hybrid FDG-PET/MRI into the algorithm of the decision-making in both lesional and non-lesional drug-resistant epileptic patients.

methodsIn a prospective study of patients suffering from drug-resistant focal epilepsy, 30 nonlesional and 30 lesional cases with discordant presurgical results were evaluated using hybrid FDG-PET/MRI.

resultsThe hybrid imaging revealed morphological lesion in 18 patients and glucose hypometabolism in 29 patients within the nonlesional group. In the MRI positive group, 4 patients were found to be nonlesional, and in 9 patients at least one more epileptogenic lesion was discovered, while in another 17 cases the original lesion was confirmed by means of hybrid FDG-PET/MRI. As to the therapeutic decision-making, these results helped to indicate resective surgery instead of intracranial EEG (iEEG) monitoring in 2 cases, to avoid any further invasive diagnostic procedures in 7 patients, and to refer 21 patients for iEEG in the nonlesional group. Hybrid FDG-PET/MRI has also significantly changed the original therapeutic plans in the lesional group. Prior to the hybrid imaging, a resective surgery was considered in 3 patients, and iEEG was planned in 27 patients. However, 3 patients became eligible for resective surgery, 6 patients proved to be inoperable instead of iEEG, and 18 cases remained candidates for iEEG due to the hybrid FDG-PET/MRI. Two patients remained candidates for resective surgery and one patient became not eligible for any further invasive intervention.

conclusionsThe results of hybrid FDG-PET/MRI significantly altered the original plans in 19 of 60 cases. The introduction of hybrid FDG-PET/MRI into the presurgical evaluation process had a potential modifying effect on clinical decision-making.

trial registrationTrial registry: Scientific Research Ethics Committee of the Medical Research Council of Hungary. TRIAL REGISTRATION NUMBER: 008899/2016/OTIG . Date of registration: 08 February 2016.

Indexed as

EpilepsyPharmaceutical PreparationsElectroencephalographyFluorodeoxyglucose F18HumansMagnetic Resonance ImagingPositron-Emission TomographyProspective StudiesFluorodeoxyglucose F18Pharmaceutical PreparationsClinical decision-makingDrug-resistant epilepsyEpilepsy surgeryHybrid FDG-PET/MRIPreoperative workflow

Identifiers

PMID34537017
PMCPMC8449490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.